Prevalence of equine herpesvirus type 2 (EHV-2) DNA in ocular swabs and its cell tropism in equine conjunctiva

Veterinary Microbiology

Volumn 118, Issue 3-4, 2006, Pages 260-266

  Borchers, K ^a   Ebert, M ^a   Fetsch, A ^a   Hammond, T ^b   Sterner Kock, A ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b ANIMAL HEALTH TRUST   (United Kingdom)

Author keywords

Conjuntiva; EHV 2; Langerhans cell; Ocular disease; Ocular swabs; PCR

Indexed keywords

VIRUS ANTIGEN; VIRUS DNA;

ANIMAL TISSUE; ARTICLE; CELL TYPE; CONJUNCTIVA; CONTROLLED STUDY; EYE; EYE DISEASE; GENOME; HERPES SIMPLEX VIRUS 2; HORSE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LACRIMAL GLAND; LANGERHANS CELL; NONHUMAN; OPTIC NERVE; POLYMERASE CHAIN REACTION; PREVALENCE; VIRUS INFECTION;

ANIMALS; ANTIGENS, VIRAL; CONJUNCTIVITIS, VIRAL; DNA, VIRAL; HERPESVIRIDAE INFECTIONS; HORSE DISEASES; HORSES; IMMUNOHISTOCHEMISTRY; LANGERHANS CELLS; POLYMERASE CHAIN REACTION; PREVALENCE; RHADINOVIRUS; TUMOR VIRUS INFECTIONS;

EQUID HERPESVIRUS 1; EQUID HERPESVIRUS 2; EQUIDAE; EQUINE HERPESVIRUS SP.; HERPESVIRIDAE; HUMAN HERPESVIRUS 2;

EID: 33751259853     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2006.07.024     Document Type: Article

References (37)

1. Ackermann M. Pathogenesis of gammaherpesvirus infections. Vet. Microbiol. 113 (2005) 211-222
2. Bagust T.J., Pascoe R.R., and Harden T.J. Studies on equine herpesviruses 3. The incidence in Queensland of three different equine herpesvirus infections. Aust. Vet. J. 48 (1972) 47-53
3. Besthorn, C., 2002. Keratiden des Pferdes und die Nachweishäufigkeit der DNS der Equinen Herpesviren Typ 2 und 5 mittels Polymerasekettenreaktion. Vet. Med. Dissertation. Ludwig-Maximilians-Universität, München.
4. Borchers K., Wolfinger U., Goltz M., Broll H., and Ludwig H. Distribution and relevance of equine herpesvirus type 2 (EHV-2) infections. Arch. Virol. 142 (1997) 917-928
5. Borchers K., Wolfinger U., Ludwig H., Thein P., Baxi S., Field H.J., and Slater J.D. Virological and molecular biological investigations into equine herpes virus type 2 (EHV-2) experimental infections. Virus Res. 55 (1998) 101-106
6. Borchers K., Brackmann J., and Kershaw O. The mouse is not permissive for equine herpesvirus 2 (EHV-2), however viral DNA persisted in lung and spleen depending on the inoculation route. Arch. Virol. 147 (2002) 1437-1444
7. Borchers K., Fetsch A., Ebert M., Mauel S., and Sterner-Kock A. Distribution and relevance of Equine Herpesvirus Type 2 and 5. Proceedings of the Annual Veterinary Herpesvirus Satellite Workshop, Proceedings of the 30th International Herpevirus Workshop. Turku, Finland, July 30-August 4, 2005 (2005)
8. Browning G.F., and Studdert M.J. Epidemiology of equine herpesvirus 2 (equine cytomegalovirus). J. Clin. Microbiol. 25 (1987) 13-16
9. Browning G.F., and Studdert M.J. Equine herpesvirus 2 (equine cytomegalovirus). Vet. Bull. 58 (1988) 775-790
10. Collinson P.N., O'Rielly J.L., Ficorilli N., and Studdert M.J. Isolation of equine herpesvirus type 2 (equine gammaherpesvirus 2) from foals with keratokonjunctivitis. J. Am. Vet. Med. Assoc. 205 (1994) 329-331
11. Craig M.I., Barrandeguy M.E., and Fernandez F.M. Equine herpesvirus 2 (EHV-2) infection in thoroughbred horses in Argentina. BMC Vet. Res. 1 (2005) 9
12. Drummer H.E., Reubel G.H., and Studdert M.J. Equine gammaherpesvirus 2 (EHV-2) is latent in B Lymphocytes. Arch. Virol. 141 (1996) 495-504
13. Dutta S.K., and Campbell D.L. Pathogenicity of equine herpesvirus: in vivo persistence in equine tissue macrophages of herpesvirus type 2 detected in monolayer macrophage cell culture. Am. J. Vet. Res. 39 (1978) 1422-1427
14. Dwyer R.M., and Vickers M.L. Ophthalmic disease outbreak. Equine Disease Quart. 5 (1997) 4-5
15. Edington N., Welch H.M., and Griffiths L. The prevalence of latent Equid herpesviruses in the tissues of 40 abattoir horses. Equine Vet. J. 26 (1994) 140-142
16. Flano E., Kim I.J., Moore J., Woodland D.L., and Blackman M.A. Differential gamma-herpesvirus distribution in distinct anatomical locations and cell subsets during persistent infection in mice. J. Immunol. 170 (2003) 3828-3834
17. Fu Z.F., Robinson A.J., Horner G.W., Dickinson L.G., Grimmett J.B., and Marshall R.B. Respiratory disease in foals and the epizootiology of equine herpesvirus type 2 infection. NZ Vet. J. 34 (1986) 152-155
18. Kemeny L.J., and Pearson J.E. Isolation of herpesvirus from equine leucocytes: comparison with equine rhinopneumonitis virus. Can. J. Comp. Med. 34 (1970) 59-65
19. Kershaw O., von Oppen T., Glitz F., Deegen E., Ludwig H., and Borchers K. Detection of equine herpesvirus 2 (EHV-2) in horses with keratokonjunctivitis. Virus Res. 80 (2001) 109-115
20. Krüdewagen E.M., Balzer H.J., and Kellner S.J. Nachweishäufigkeit von Equinen Herpesviren 2 und 5 am Pferdeauge-Vergleich der Nachweismöglichkeiten mittels exfoliater Zytologie und Polymerasekettenreaktion. Pferdeheilkunde 17 (2001) 444-452
21. Matthews A.G., and Handscombe M.C. Superficial keratitis in the horse: treatment with the antiviral drug idoxuridine. Equine Vet. J. Suppl. 2 (1983) 138-140
22. Miller T.R., Gaskin J.M., Whitley R.D., and Wittcoff M.L. Herpetic keratitis in a horse. Equine Vet. J. 10 (1990) 15-17
23. Murray M.J., Eichorn E.S., Dubovi E.J., Ley W.B., and Cavey D.M. Equine herpesvirus type 2: prevalence and seroepidemiology in foals. Equine Vet. J. 28 (1996) 432-436
24. Nordengrahn A., Rusvai M., Merza M., Ekstrom J., Morein B., and Belak S. Equine herpesvirus type 2 (EHV-2) as a predisposing factor for Rhodococcus equi pneumonia in foals: prevention of the bifactorial disease with EHV-2 immunostimulating complexes. Vet. Microbiol. 51 (1996) 55-68
25. Nordengrahn A., Merza A., Ros C., Lindholm A., Palfi V., Hannant D., and Belák S. Prevalence of equine herpesvirus types 2 and 5 in horse populations by using type-specific PCR assays. Vet. Res. 33 (2002) 251-259
26. Pálfi V., Belák S., and Molnar T. Isolation of equine herpesvirus type 2 from foals showing respiratory symptoms. Zentralbl. Veterinärmed. Reihe B 25 (1978) 165-167
27. Rizvi S.M., Slater J.D., Wolfinger U., Borchers K., Field H.J., and Slade A.J. Detection and distribution of equine herpesvirus 2 DNA in the central and peripheral nervous systems of ponies. J. Gen. Virol. 78 (1997) 1115-1118
28. Rode H.-J., Janssen W., Rösen-Wolff A., Bugert J.J., Thein P., Becker Y., and Darai G. The genome of equine herpesvirus type 2 harbors an interleukin10 (IL 10) like gene. Virus Genes 7 (1993) 111-116
29. Rode H.J., Bugert J.J., Handermann M., Schnitzler P., Kehm R., Janssen W., Delius H., and Darai G. Molecular characterization and determination of the coding capacity of the genome of equine herpesvirus type 2 between the genome coordinates 0.235 and 0.258 (the Eco RI DNA fragment N; 4.2 kbp). Virus Genes 9 (1994) 61-75
30. Roeder P.L., and Scott G.R. The prevalence of equid herpesvirus 2 infections. Vet. Rec. 96 (1975) 404-405
31. Rusczcyk A., Cywinska A., and Banbura M.W. Equine herpes virus 2 infection in horse populations in Poland. Acta Virol. 48 (2004) 189-192
32. Schlocker N., Gerber-Bretscher R., and von Fellenberg R. Equine herpesvirus 2 in pulmonary macrophages of horses. Am. J. Vet. Res. 56 (1995) 749-754
33. Telford E.A.R., Studdert M.J., Agius C.T., Watson M.S., Aird H.C., and Davison A.J. Equine herpesviruses 2 and 5 are gamma-herpesviruses. Virology 195 (1993) 492-499
34. Thein P. Virusbedingte Keratitis beim Pferd. Zentralbl. Veterinarmed. 25 (1976) 235-240
35. Thein P., and Böhm D. Ätiologie und Klinik einer virusbedingten Keratokonjunktivitis beim Fohlen. Zentralbl. Veterinärmed. Reihe B 23 (1976) 507-519
36. von Oppen T., Kershaw O., Borchers K., Glitz F., and Boevé M.H. Keratitiden des Pferdes und Nachweis von equinem Herpesvirus Typ 2 (EHV-2). Tierärztl. Prax. 29 (2001) 227-233
37. Zerbini M., Gentilomi G., Cricca M., Manaresi E., Bonvicini F., and Musiani M. Related A system to enhance the sensitivity of digoxigenin-labelled probe: detection of B19 DNA in serum samples. J. Virol. Meth. 93 (2001) 137-144